查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947823

消费者基因体学市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、最终用户、组件、功能、设备及模式划分

Consumer Genomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Functionality, Equipment, Mode
出版日期: | 出版商: Global Insight Services | 英文 336 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计消费者基因体学市场将从2024年的21亿美元成长到2034年的194亿美元，复合年增长率约为28.3%。消费者基因组学市场涵盖使个人能够获取自身基因资讯的服务和产品。该市场包括面向消费者的DNA检测套组、祖源追踪和个人化健康咨询。推动市场成长的因素包括基因组学技术的进步、定序成本的下降以及人们对基因健康影响的认识不断提高，而这又源于人们对个人化医疗保健和祖源研究日益增长的兴趣。个人化医疗、健康和预防保健领域的机会正在推动该产业的扩张。

受消费者对个人化健康和祖源资讯日益增长的兴趣推动，消费者基因组学市场正经历强劲增长。消费者检测领域是成长的主要驱动力，其中祖源和健康风险检测尤为受欢迎。祖源检测持续吸引消费者，源自于他们对自身根源和家族连结的好奇心。由于人们越来越重视主动健康管理，健康风险检测的需求也保持旺盛。营养基因组学专注于营养素与基因之间的相互作用，随着消费者越来越重视个人化饮食建议，该领域正蓬勃发展。药物基因组学领域也正在兴起，它基于基因组成提供药物反应的见解。人工智慧和机器学习在基因组数据分析中的应用，有助于提高检测准确性和消费者满意度。隐私问题仍然是一个挑战，各公司正在优先考虑资料安全和透明度。与医疗保健和科技公司的合作正在拓展服务范围，进一步推动市场成长。随着意识提升和技术的不断进步，该市场蕴藏着巨大的潜力。

市场区隔
类型 预测性检测、基因带原检测、营养基因组学、祖源检测、药物基因组学、娱乐基因组学
产品 试剂盒、试剂、软体、平台、耗材
服务 遗传咨询、数据解读、检体收集、个人化报告撰写和咨询服务
科技 次世代定序、聚合酵素链锁反应、微阵列、SNP基因型鉴定
目的 健康与保健、诊断、调查、法医学
最终用户 消费者、研究机构、医疗保健提供者、製药公司
成分 硬体、软体和服务
功能 数据分析、样本处理和报告生成
装置 定序仪，分析器
模式 线上、线下

受竞争性定价策略和创新产品推出的影响，消费者基因组学市场正经历市场份额的动态变化。主要企业正致力于透过个人化基因组服务提升消费者参与度。同时，面向更广泛人群的新型、用户友好的基因组检测套组的推出，也推动了这一趋势。此外，旨在拓展产品系列和巩固市场影响的策略联盟与合作，也是该市场的重要特征。人们对个人健康和祖源的日益关注和兴趣，也推动了市场成长。消费者基因组学市场的竞争日趋激烈，主要参与者正大力投资研发。 23andMe 和 AncestryDNA 等公司引领潮流，利用先进技术保持其竞争优势。监管的影响，尤其是在北美和欧洲，对塑造市场动态主导。这些法规确保了消费者安全和资料隐私，从而增强了信任和普及度。市场对消费者基因检测需求的快速成长，进一步凸显了严格遵守监管规定的必要性。总体而言，在技术进步和消费者偏好变化的推动下，市场预计将经历强劲成长。

主要趋势和驱动因素：

受消费者对个人化健康和祖源资讯日益增长的兴趣推动，消费者基因组学市场正经历强劲增长。基因组学技术的进步使DNA检测更加便利和经济实惠，鼓励更多消费者考虑进行基因检测。基因组学技术的普及化正在推动新一轮的消费者参与，并进一步加速市场扩张。一个关键趋势是将人工智慧（AI）和机器学习应用于基因组学领域，从而改善数据解读并提供更准确的健康预测。企业正在利用人工智慧提供个人化的健康建议，提高客户满意度和留存率。另一个趋势是，随着消费者越来越意识到共用基因资料的影响，隐私和资料安全问题日益受到重视。企业正在投资强大的安全措施，以建立信任并确保合规性。此外，基因组学公司和医疗保健提供者之间的合作正在兴起，旨在将基因资讯融入日常医疗保健。这种融合为个人化医疗和预防保健创造了机会，有助于改善患者的治疗效果。由于在健康、营养管理和疾病预防方面的应用不断扩大，消费者基因组学市场预计将持续成长，为创新和投资提供有吸引力的机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 预测性测试
    • 载体测试
    • 营养基因体学
    • 祖源测试
    • 药物基因组学
    • 休閒基因组学
  • 市场规模及预测：依产品划分
    • 成套工具
    • 试剂
    • 软体
    • 平台
    • 消耗品
  • 市场规模及预测：依服务划分
    • 遗传咨询
    • 数据解读
    • 检体采集
    • 个人报告
    • 咨询服务
  • 市场规模及预测：依技术划分
    • 次世代定序
    • 聚合酵素链锁反应
    • 微阵列
    • SNP基因分型
  • 市场规模及预测：依应用领域划分
    • 健康与保健
    • 诊断
    • 研究
    • 法医学
  • 市场规模及预测：依最终用户划分
    • 直接面向消费者
    • 研究所
    • 医疗保健提供者
    • 製药公司
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
  • 市场规模及预测：依功能划分
    • 数据分析
    • 检体处理
    • 报告
  • 市场规模及预测：依设备划分
    • 序列器
    • 分析器
  • 市场规模及预测：按模式
    • 在线的
    • 离线

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • 23and Me
  • Ancestry
  • My Heritage
  • Living DNA
  • Family Tree DNA
  • Nebula Genomics
  • Dante Labs
  • Circle DNA
  • Tellme Gen
  • DNAfit
  • Mapmygenome
  • Xcode Life
  • Gene by Gene
  • Veritas Genetics
  • Helix
  • Color Genomics
  • Genetic Direction
  • Genomelink
  • Orig3n
  • Basepaws

第九章：关于我们

简介目录
Product Code: GIS26478

Consumer Genomics Market is anticipated to expand from $2.1 billion in 2024 to $19.4 billion by 2034, growing at a CAGR of approximately 28.3%. The Consumer Genomics Market encompasses services and products that enable individuals to access information about their genetic makeup. This market includes direct-to-consumer DNA testing kits, ancestry tracing, and personalized health insights. As consumer interest in personalized health and ancestry grows, the market is driven by advancements in genomics technology, reduced sequencing costs, and increased awareness of genetic health implications. The sector is poised for expansion, with opportunities in personalized medicine, wellness, and preventative care.

The Consumer Genomics Market is experiencing robust growth, fueled by rising consumer interest in personalized health and ancestry insights. The direct-to-consumer testing segment is leading, with ancestry and health risk tests being particularly popular. Ancestry testing continues to captivate consumers, driven by curiosity about heritage and familial connections. Health risk testing follows closely, as individuals seek proactive health management. Nutrigenomics, focusing on the interaction between nutrition and genes, is gaining momentum as consumers prioritize tailored dietary recommendations. The pharmacogenomics sub-segment is also emerging, offering insights into drug responses based on genetic makeup. The integration of AI and machine learning in genomic data analysis is enhancing test accuracy and consumer satisfaction. Privacy concerns remain a challenge, prompting companies to emphasize data security and transparency. Partnerships with healthcare providers and tech firms are expanding service offerings, further driving market growth. As consumer awareness and technological advancements continue, the market is poised for significant opportunities.

Market Segmentation
TypePredictive Testing, Carrier Testing, Nutrigenomics, Ancestry Testing, Pharmacogenomics, Recreational Genomics
ProductKits, Reagents, Software, Platforms, Consumables
ServicesGenetic Counseling, Data Interpretation, Sample Collection, Personalized Reports, Consultation Services
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray, SNP Genotyping
ApplicationHealth and Wellness, Diagnostics, Research, Forensics
End UserDirect-to-Consumer, Research Institutes, Healthcare Providers, Pharmaceutical Companies
ComponentHardware, Software, Services
FunctionalityData Analysis, Sample Processing, Report Generation
EquipmentSequencers, Analyzers
ModeOnline, Offline

The consumer genomics market is witnessing a dynamic shift in market share, driven by competitive pricing strategies and innovative product launches. Leading companies are focusing on enhancing consumer engagement through personalized genomic services. This trend is complemented by the introduction of new, user-friendly genomic testing kits, which cater to a broader audience. The market is also characterized by strategic partnerships and collaborations, aimed at expanding product portfolios and enhancing market presence. Additionally, the increasing awareness and interest in personal health and ancestry are propelling market growth. Competition in the consumer genomics market is intensifying, with key players investing significantly in research and development. Companies such as 23andMe and AncestryDNA are leading the charge, leveraging advanced technologies to maintain competitive advantage. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics. These regulations ensure consumer safety and data privacy, fostering trust and adoption. The market is also witnessing a surge in demand for direct-to-consumer genetic testing, further emphasizing the need for stringent regulatory compliance. Overall, the market is poised for robust growth, driven by technological advancements and evolving consumer preferences.

Geographical Overview:

The consumer genomics market is witnessing robust growth across various regions, each exhibiting unique opportunities. North America leads the market, driven by high consumer awareness and advanced healthcare infrastructure. The United States is at the forefront, with significant investments in genomics research and personalized medicine initiatives. Europe follows closely, with countries like the United Kingdom and Germany spearheading genomics research and innovation. The region's regulatory frameworks and emphasis on ethical considerations bolster market growth. In Asia Pacific, the market is expanding rapidly, propelled by rising disposable incomes and increasing demand for personalized healthcare solutions. China and India are emerging as key players, with substantial investments in genomics research and biotechnology. Latin America presents untapped potential, with Brazil and Mexico showing increasing interest in genomics applications. The Middle East & Africa are gradually recognizing the benefits of genomics, with initiatives to integrate genomics into healthcare systems and drive economic growth.

Global tariffs and geopolitical risks are significantly influencing the Consumer Genomics Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are bolstering their genomic research capabilities to mitigate reliance on foreign technologies amidst trade tensions. China's focus on self-sufficiency is driving investment in domestic genomic technologies, while Taiwan leverages its advanced biotech sector to maintain market leadership despite geopolitical vulnerabilities. The global genomics market is experiencing robust growth, driven by increased demand for personalized medicine and advanced healthcare solutions. By 2035, the market is expected to evolve with enhanced regional collaborations and innovation-driven growth. Middle East conflicts could disrupt energy prices, indirectly affecting supply chains and operational costs in the genomics sector, necessitating strategic risk management.

Key Trends and Drivers:

The consumer genomics market is experiencing robust growth, driven by increasing consumer interest in personalized health and ancestry insights. Advances in genomic technologies are making DNA testing more accessible and affordable, encouraging a broader demographic to explore genetic testing. This democratization of genomics is fostering a new wave of consumer engagement, further propelling market expansion. A significant trend is the integration of artificial intelligence and machine learning in genomics, enhancing data interpretation and providing more precise health predictions. Companies are leveraging AI to offer personalized health recommendations, thereby improving customer satisfaction and retention. Another trend is the growing focus on privacy and data security, as consumers become more aware of the implications of sharing genetic data. Companies are investing in robust security measures to build trust and ensure compliance with regulations. Additionally, collaborations between genomics companies and healthcare providers are emerging, aiming to integrate genetic insights into routine healthcare. This convergence is creating opportunities for personalized medicine and preventative care, thereby enhancing patient outcomes. The consumer genomics market is poised for continuous growth, with expanding applications in wellness, nutrition, and disease prevention, offering lucrative opportunities for innovation and investment.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Predictive Testing
    • 4.1.2 Carrier Testing
    • 4.1.3 Nutrigenomics
    • 4.1.4 Ancestry Testing
    • 4.1.5 Pharmacogenomics
    • 4.1.6 Recreational Genomics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Kits
    • 4.2.2 Reagents
    • 4.2.3 Software
    • 4.2.4 Platforms
    • 4.2.5 Consumables
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Genetic Counseling
    • 4.3.2 Data Interpretation
    • 4.3.3 Sample Collection
    • 4.3.4 Personalized Reports
    • 4.3.5 Consultation Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 Microarray
    • 4.4.4 SNP Genotyping
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Health and Wellness
    • 4.5.2 Diagnostics
    • 4.5.3 Research
    • 4.5.4 Forensics
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Direct-to-Consumer
    • 4.6.2 Research Institutes
    • 4.6.3 Healthcare Providers
    • 4.6.4 Pharmaceutical Companies
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Data Analysis
    • 4.8.2 Sample Processing
    • 4.8.3 Report Generation
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Sequencers
    • 4.9.2 Analyzers
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Online
    • 4.10.2 Offline

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Equipment
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Equipment
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Equipment
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Equipment
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Equipment
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Equipment
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Equipment
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Equipment
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Equipment
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Equipment
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Equipment
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Equipment
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Equipment
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Equipment
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Equipment
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Equipment
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Equipment
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Equipment
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Equipment
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Equipment
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Equipment
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Equipment
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Equipment
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Equipment
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 23and Me
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Ancestry
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 My Heritage
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Living DNA
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Family Tree DNA
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Nebula Genomics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Dante Labs
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Circle DNA
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Tellme Gen
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 DNAfit
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Mapmygenome
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Xcode Life
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Gene by Gene
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Veritas Genetics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Helix
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Color Genomics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Genetic Direction
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Genomelink
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Orig3n
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Basepaws
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us